New appointees to Board and Leadership team bring global strategic, operational and commercial experience from across the medical device sector. New headquarters and state-of-the-art manufacturing ...
Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress ...
Through Nexalin America, the Company’s division dedicated to U.S. government engagement, the Company participated in advocacy ...
Breakthrough Preclinical Result in Epilepsy Treatment These findings strengthen our confidence as we progress toward ...
At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...
As Valentine’s Day gifting trends continue to shift toward wellness-focused products, neuromodulation devices are ...
Brain Performance Technologies launches Interventional Psychiatry, expanding access to precision neuromodulation for ...
Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth ...
The Indo-French Centre for AI in Health, inaugurated by President Emmanuel Macron and Health Minister J P Nadda, will anchor ...
Magnus Medical Inc., exclusive licensee of a collection of pioneering accelerated neuromodulation patents, today reaffirmed its commitment to protecting the intellectual property behind SAINT® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results